Dr. David Corney is a principal scientist within the Process Development team at Azenta Life Sciences. Over the past eight years, he has evaluated emerging technologies for their GENEWIZ portfolio, leading the development and commercialization of their proteomics, long-read sequencing, and single-cell sequencing services. Dr. Corney earned his Ph.D. in Environmental Toxicology from Cornell University and performed postdoctoral studies at Stanford University and Princeton University, employing various genomic approaches to study cancer stem cells.